•   
  •   
  •   

Technology Move Over, Pot: Psychedelic Companies Are About to Go Public

12:00  12 february  2020
12:00  12 february  2020 Source:   msn.com

Former Bank of Canada governor Mark Carney urges financial sector to act against climate change

  Former Bank of Canada governor Mark Carney urges financial sector to act against climate change The UN's incoming special envoy for climate change, former Bank of Canada governor Mark Carney, is likening the climate crisis to a financial crisis — and says action by the financial sector to help tackle the issue is "absolutely necessary."In an interview broadcast on BBC Radio 4 Monday, Carney, whose tenure as Bank of England governor is set to end Jan. 31, 2020, said while the financial sector has begun to make changes in the way it invests in public pensions funds, its action has been too slow.

The first companies developing medical treatments from psychedelic drugs like LSD, ketamine and the active ingredient in magic mushrooms are Yet a growing number of companies are conducting clinical trials of psychedelic treatments for everything from depression to post-traumatic stress

Widgetized Section. Go to Admin » Appearance » Widgets » and move Gabfire Widget: Social into that MastheadOverlay zone. “I think that the psychedelics industry could be much bigger than the cannabis industry because it’s going to attract institutional capital and already is starting to.”

(Photo by Daniel Berehulak/Getty Images)© 2005 Getty Images (Photo by Daniel Berehulak/Getty Images)

The first companies developing medical treatments from psychedelic drugs like LSD, ketamine and the active ingredient in magic mushrooms are gearing up to list on Canadian stock exchanges.

Mind Medicine Inc., which is undertaking clinical trials of psychedelic-based drugs, intends to list on Toronto’s NEO Exchange by the first week of March, said JR Rahn, the company’s co-founder and co-chief executive officer. A NEO spokesman confirmed the listing, which is pending final approvals.

The company plans to list via a reverse takeover under the ticker MMED. It’s not yet generating revenue and is targeting a valuation of approximately $50 million, Rahn said. MindMed counts former Canopy Growth Corp. co-CEO Bruce Linton as a director and Shark Tank star Kevin O’Leary as an investor.

Justin Bieber on drug abuse: 'It was legit crazy scary'

  Justin Bieber on drug abuse: 'It was legit crazy scary' Justin Bieber on drug abuse: 'It was legit crazy scary'Bieber, 25, has written on social media in the past year about his struggles with depression, drugs and fame, but he went into detail on camera for the first time in a documentary series about his life.

Move over , pot : Psychedelic companies are about to go public . The man, known as Al, started consuming prescription opioids to manage pain caused by a serious workplace accident that left him disabled and in constant pain that refuses to go away even after eight surgeries.

Bloomberg the Company & Its Products Bloomberg Anywhere Remote LoginBloomberg Anywhere Login Bloomberg Terminal Demo Request.

“Our ambition is to be one of the first publicly listed neuro-pharmaceutical companies developing psychedelic medicines,” Rahn said in a phone interview.

Clinical trials

For those who are still getting used to legal marijuana, the idea of publicly traded companies working with psychedelic drugs like MDMA and psilocybin, which is derived from magic mushrooms, may sound a bit out there.

Yet a growing number of companies are conducting clinical trials of psychedelic treatments for everything from depression to post-traumatic stress disorder, and some have recently received the blessing of the U.S. Food and Drug Administration. This has created a legal way for these companies to conduct research on otherwise illegal drugs, opening the door to public listings.

Encana shareholders vote 90 per cent for name change, Denver HQ move

  Encana shareholders vote 90 per cent for name change, Denver HQ move CALGARY — Shareholders in Encana Corp. have voted overwhelmingly in favour of the oil and gas company moving its headquarters to Denver from Calgary and changing its name to Ovintiv Inc. CEO Doug Suttles says the 90 per cent vote in favour of the resolution shows clear support for the long-standing Canadian company's decision to move its corporate home south of the border, despite public criticism from Encana founder Gwyn Morgan and shareholder Letko, Brosseau & Associates Inc.

ATAI is perhaps the most publicized psychedelic medicine company , but it’s not the only one. Believe it or not, there are already publicly That’s because shroom stocks face a similar logistical issue to pot stocks: Since their core business is technically illegal under U.S. law, they have limited access to

Public companies , and those that are about to go public , have their annual and quarterly financial statements scrutinized by investors and analysts. Private companies considering going public often assess their own financial statements and take any write-offs they are allowed under Generally

In late 2018, the FDA gave “breakthrough therapy” status to a psilocybin treatment developed by London-based Compass Pathways Ltd. for clinical depression, expediting the development process.

Meanwhile, Toronto-based MindMed is preparing a Phase 2 clinical trial into the use of a non-hallucinogenic compound based on a psychedelic called ibogaine to treat opioid addiction, which will be conducted in New York and governed by the FDA.

Compass Pathways declined to comment on whether it’s planning a public listing, but the company is “always looking at options to ensure continued growth and funding,” chief communications officer Tracy Cheung said in an email.

Read more: Peter Thiel-Backed Psilocybin Startup Edges Toward FDA Approval

The Canadian Securities Exchange, which has become the go-to bourse for U.S. cannabis companies that can’t list in their home country, is also expecting listings from psychedelic drug companies in 2020.

Trudeau promises $192M on developing vaccines for coronavirus

  Trudeau promises $192M on developing vaccines for coronavirus Prime Minister Justin Trudeau says Canada is spending $192 million on developing and producing vaccines for the novel coronavirus. He says being prepared to mass-produce a vaccine, no matter who creates it, will be essential for suppressing COVID-19 in Canada in the long run. More ComingThe money will be distributed to a number of different companies and universities in the drive to find a way to stop the illness's spread.

Going public refers to a private company 's initial public offering (IPO), thus becoming a publicly traded and owned entity. Going public increases prestige and helps a company raise capital to invest in future operations, expansion, or acquisitions.

Many reasons exist for a public company to go private. Privatization can give management more time to make As acquirers typically pay at least a 20% to 40% premium over the current stock price, they can entice CEOs and other managers of public Many stockholders of public companies are also

The FDA has “given clearance for a variety of trials at this point and it looks like they are going to be expanding that framework,” said Richard Carleton, CEO of the Canadian Securities Exchange. “If that is the case then I’m certain we’ll see our first issuers probably before the middle of the year.”

Institutional capital

There’s growing investor interest in psychedelics, said Ronan Levy, executive chairman of Field Trip Psychedelics Inc. Field Trip is building a network of clinics focused on ketamine-enhanced psychotherapy, with the first one opening in Toronto next month and others planned for New York City and Los Angeles. It’s also conducting research into psilocybin at the University of the West Indies in Jamaica.

Last week, Field Trip closed a Series A financing round that raised $8.5 million from a variety of investors including cannabis-focused asset manager Silver Spike Capital and Harris Fricker, the former CEO of GMP Capital Inc., which helped a number of marijuana companies go public.

The funding round attracted interest from all over the world, including “some very large Silicon Valley tech investors and entrepreneurs,” Levy said.

Latest job numbers peg Edmonton as having highest unemployment rate of Canadian cities

  Latest job numbers peg Edmonton as having highest unemployment rate of Canadian cities Edmonton ended 2019 with the highest unemployment rate of Canadian metropolitan areas with eight per cent of employable folks looking for work, according to the latest data from Statistics Canada. The agency’s labour force survey , updated Friday, showed Edmonton and Alberta have the dubious distinction of bucking a national trend of increasing employment rates during 2019. Although the forecast for growth in the Edmonton area is rosier for 2020, City of Edmonton senior economist Felicia Mutheardy said she’s “not expecting brilliant results” this year. “We still see this as us being on the road to recovery,” Mutheardy said Friday.

Field Trip is considering a public listing, although Levy also sees further opportunities to raise private funding. “All options are on the table and we’ll ultimately make the decision that’s going to lead to the lowest cost of capital,” he said.

Unlike cannabis, which remains federally illegal in the U.S., the work psychedelic companies are doing is legal. This creates “greater opportunity to access growth capital from private investors in the U.S. who may not touch cannabis,” he said.

It also sets the industry apart from cannabis, which has seen stock prices collapse amid slower-than-expected sales in Canada and ongoing federal illegality in the U.S.

“I think that the psychedelics industry could be much bigger than the cannabis industry because it’s going to attract institutional capital and already is starting to,” Rahn said. “It’s also going to be a more concentrated space because the barriers to entry are much higher.”

(Adds quote from Levy in 4th-last paragraph, notes that Mind Medicine’s treatment is based on a compound of ibogaine in the 8th paragraph)

To contact the reporter on this story: Kristine Owram in New York at kowram@bloomberg.net

To contact the editors responsible for this story: Brad Olesen at bolesen3@bloomberg.net, Derek DeCloet, Jacqueline Thorpe

For more articles like this, please visit us at bloomberg.com

©2020 Bloomberg L.P.

Halifax man refuses to pay booting company, waits five hours for car to be freed .
A Halifax resident who waited five hours in a parking lot after refusing to pay a company that booted his car wants stricter oversight of an industry he says uses “predatory tactics and intimidation.”Joshua Bernas thought he was parking in a visitor spot when he visited an acupuncturist at 50 Bedford Highway on Saturday. When he realized the office was closed, he returned to his car to find someone securing a boot to his tire.

—   Share news in the SOC. Networks

Topical videos:

usr: 4
This is interesting!